APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chromosomal Microarray Analysis (CMA) Testing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chromosomal Microarray Analysis (CMA) Testing Industry Growth and Trends Forecast to 2032

16 January 2026102 pages

Choose your research edition.

Industry ResearchChromosomal Microarray Analysis (CMA) Testing Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Chromosomal Microarray Analysis (CMA) Testing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chromosomal Microarray Analysis (CMA) Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chromosomal Microarray Analysis (CMA) Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Chromosomal Microarray Analysis (CMA) Testing Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

According to APO Research, the global Chromosomal Microarray Analysis (CMA) Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chromosomal Microarray Analysis (CMA) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chromosomal Microarray Analysis (CMA) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chromosomal Microarray Analysis (CMA) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Chromosomal Microarray Analysis (CMA) Testing market include Baylor Genetics, MedGenome Labs, Illumina Inc., CD Genomics, Thermo Fisher, Agilent, GeneDx, Quest Diagnostics and LabCorp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chromosomal Microarray Analysis (CMA) Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chromosomal Microarray Analysis (CMA) Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chromosomal Microarray Analysis (CMA) Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chromosomal Microarray Analysis (CMA) Testing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Chromosomal Microarray Analysis (CMA) Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chromosomal Microarray Analysis (CMA) Testing Market by Company

Baylor Genetics

MedGenome Labs

Illumina Inc.

CD Genomics

Thermo Fisher

Agilent

GeneDx

Quest Diagnostics

LabCorp

Lineagen

Invitae

Centogene

Chromosomal Microarray Analysis (CMA) Testing Segment by Type

Single Nucleotide Polymorphism (SNP)

Comparative Genomic Hybridization (CGH)

Chromosomal Microarray Analysis (CMA) Testing Segment by Application

Medical

Laboratory

Clinical

Others

Chromosomal Microarray Analysis (CMA) Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chromosomal Microarray Analysis (CMA) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chromosomal Microarray Analysis (CMA) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chromosomal Microarray Analysis (CMA) Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Chromosomal Microarray Analysis (CMA) Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Chromosomal Microarray Analysis (CMA) Testing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Region (2021-2026) Table 4. Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Region (2027-2032) Table 6. Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Type (2021-2026) Table 9. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Application (2021-2026) Table 24. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Chromosomal Microarray Analysis (CMA) Testing Industry Trends Table 37. Chromosomal Microarray Analysis (CMA) Testing Industry Drivers Table 38. Chromosomal Microarray Analysis (CMA) Testing Industry Opportunities and Challenges Table 39. Chromosomal Microarray Analysis (CMA) Testing Industry Restraints Table 40. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Company (2021-2026) Table 42. Global Chromosomal Microarray Analysis (CMA) Testing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Chromosomal Microarray Analysis (CMA) Testing Key Company Headquarters & Area Served Table 44. Global Chromosomal Microarray Analysis (CMA) Testing Company, Product Type & Application Table 45. Global Chromosomal Microarray Analysis (CMA) Testing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Chromosomal Microarray Analysis (CMA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Baylor Genetics Company Information Table 49. Baylor Genetics Business Overview Table 50. Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 52. Baylor Genetics Recent Development Table 53. MedGenome Labs Company Information Table 54. MedGenome Labs Business Overview Table 55. MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 57. MedGenome Labs Recent Development Table 58. Illumina Inc. Company Information Table 59. Illumina Inc. Business Overview Table 60. Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 62. Illumina Inc. Recent Development Table 63. CD Genomics Company Information Table 64. CD Genomics Business Overview Table 65. CD Genomics Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. CD Genomics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 67. CD Genomics Recent Development Table 68. Thermo Fisher Company Information Table 69. Thermo Fisher Business Overview Table 70. Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 72. Thermo Fisher Recent Development Table 73. Agilent Company Information Table 74. Agilent Business Overview Table 75. Agilent Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Agilent Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 77. Agilent Recent Development Table 78. GeneDx Company Information Table 79. GeneDx Business Overview Table 80. GeneDx Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GeneDx Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 82. GeneDx Recent Development Table 83. Quest Diagnostics Company Information Table 84. Quest Diagnostics Business Overview Table 85. Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 87. Quest Diagnostics Recent Development Table 88. LabCorp Company Information Table 89. LabCorp Business Overview Table 90. LabCorp Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. LabCorp Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 92. LabCorp Recent Development Table 93. Lineagen Company Information Table 94. Lineagen Business Overview Table 95. Lineagen Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Lineagen Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 97. Lineagen Recent Development Table 98. Invitae Company Information Table 99. Invitae Business Overview Table 100. Invitae Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Invitae Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 102. Invitae Recent Development Table 103. Centogene Company Information Table 104. Centogene Business Overview Table 105. Centogene Chromosomal Microarray Analysis (CMA) Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Centogene Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 107. Centogene Recent Development Table 108. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2026) Table 111. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Chromosomal Microarray Analysis (CMA) Testing Market Share Forecast by Country (2027-2032) Table 113. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2026) Table 116. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Chromosomal Microarray Analysis (CMA) Testing Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2026) Table 121. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Share Forecast by Country (2027-2032) Table 123. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2026) Table 126. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2026) Table 131. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Chromosomal Microarray Analysis (CMA) Testing Product Image Figure 3. Global Chromosomal Microarray Analysis (CMA) Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Chromosomal Microarray Analysis (CMA) Testing Market Size (2021-2032) & (US$ Million) Figure 5. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Region: 2025 VS 2032 Figure 6. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Region (2021-2032) Figure 7. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Single Nucleotide Polymorphism (SNP) Image Figure 13. Global Single Nucleotide Polymorphism (SNP) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Comparative Genomic Hybridization (CGH) Image Figure 15. Global Comparative Genomic Hybridization (CGH) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Type 2025 VS 2032 Figure 18. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Type (2021-2032) Figure 19. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Type (2021-2032) Figure 21. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Type (2021-2032) Figure 23. Medical Image Figure 24. Global Medical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Laboratory Image Figure 26. Global Laboratory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Clinical Image Figure 28. Global Clinical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Application 2025 VS 2032 Figure 33. North America Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Application (2021-2032) Figure 34. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Application (2021-2032) Figure 36. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Chromosomal Microarray Analysis (CMA) Testing Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Chromosomal Microarray Analysis (CMA) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2032) Figure 43. Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Chromosomal Microarray Analysis (CMA) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2032) Figure 46. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2032) Figure 49. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2032) Figure 52. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Single Nucleotide Polymorphism (SNP)
  • Comparative Genomic Hybridization (CGH)
Applications
  • Medical
  • Laboratory
  • Clinical
  • Others
Companies covered
  • Baylor Genetics
  • MedGenome Labs
  • Illumina Inc.
  • CD Genomics
  • Thermo Fisher
  • Agilent
  • GeneDx
  • Quest Diagnostics
  • LabCorp
  • Lineagen
  • Invitae
  • Centogene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Chromosomal Microarray Analysis (CMA) Testing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2021-2032)
  5. 1.4.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2021-2026)
  6. 1.4.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Chromosomal Microarray Analysis (CMA) Testing Market Size (2021-2032)
  8. 1.5.1 North America Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (2021-2032)
2 Chromosomal Microarray Analysis (CMA) Testing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Single Nucleotide Polymorphism (SNP)
  3. 2.1.2 Comparative Genomic Hybridization (CGH)
  4. 2.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Type
  5. 2.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Chromosomal Microarray Analysis (CMA) Testing Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Chromosomal Microarray Analysis (CMA) Testing Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Regions
  9. 2.3.1 North America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Type (2021-2026)
3 Chromosomal Microarray Analysis (CMA) Testing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical
  3. 3.1.2 Laboratory
  4. 3.1.3 Clinical
  5. 3.1.4 Others
  6. 3.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Application
  7. 3.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Chromosomal Microarray Analysis (CMA) Testing Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Chromosomal Microarray Analysis (CMA) Testing Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Regions
  11. 3.3.1 North America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Chromosomal Microarray Analysis (CMA) Testing Industry Trends
  2. 4.2 Chromosomal Microarray Analysis (CMA) Testing Industry Drivers
  3. 4.3 Chromosomal Microarray Analysis (CMA) Testing Industry Opportunities and Challenges
  4. 4.4 Chromosomal Microarray Analysis (CMA) Testing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Chromosomal Microarray Analysis (CMA) Testing Revenue (2021-2026)
  2. 5.2 Global Chromosomal Microarray Analysis (CMA) Testing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Chromosomal Microarray Analysis (CMA) Testing Key Company Headquarters & Area Served
  4. 5.4 Global Chromosomal Microarray Analysis (CMA) Testing Company, Product Type & Application
  5. 5.5 Global Chromosomal Microarray Analysis (CMA) Testing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Chromosomal Microarray Analysis (CMA) Testing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Chromosomal Microarray Analysis (CMA) Testing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Chromosomal Microarray Analysis (CMA) Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Baylor Genetics
  2. 6.1.1 Baylor Genetics Company Information
  3. 6.1.2 Baylor Genetics Business Overview
  4. 6.1.3 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  6. 6.1.5 Baylor Genetics Recent Developments
  7. 6.2 MedGenome Labs
  8. 6.2.1 MedGenome Labs Company Information
  9. 6.2.2 MedGenome Labs Business Overview
  10. 6.2.3 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  12. 6.2.5 MedGenome Labs Recent Developments
  13. 6.3 Illumina Inc.
  14. 6.3.1 Illumina Inc. Company Information
  15. 6.3.2 Illumina Inc. Business Overview
  16. 6.3.3 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  18. 6.3.5 Illumina Inc. Recent Developments
  19. 6.4 CD Genomics
  20. 6.4.1 CD Genomics Company Information
  21. 6.4.2 CD Genomics Business Overview
  22. 6.4.3 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  24. 6.4.5 CD Genomics Recent Developments
  25. 6.5 Thermo Fisher
  26. 6.5.1 Thermo Fisher Company Information
  27. 6.5.2 Thermo Fisher Business Overview
  28. 6.5.3 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  30. 6.5.5 Thermo Fisher Recent Developments
  31. 6.6 Agilent
  32. 6.6.1 Agilent Company Information
  33. 6.6.2 Agilent Business Overview
  34. 6.6.3 Agilent Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Agilent Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  36. 6.6.5 Agilent Recent Developments
  37. 6.7 GeneDx
  38. 6.7.1 GeneDx Company Information
  39. 6.7.2 GeneDx Business Overview
  40. 6.7.3 GeneDx Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GeneDx Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  42. 6.7.5 GeneDx Recent Developments
  43. 6.8 Quest Diagnostics
  44. 6.8.1 Quest Diagnostics Company Information
  45. 6.8.2 Quest Diagnostics Business Overview
  46. 6.8.3 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  48. 6.8.5 Quest Diagnostics Recent Developments
  49. 6.9 LabCorp
  50. 6.9.1 LabCorp Company Information
  51. 6.9.2 LabCorp Business Overview
  52. 6.9.3 LabCorp Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 LabCorp Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  54. 6.9.5 LabCorp Recent Developments
  55. 6.10 Lineagen
  56. 6.10.1 Lineagen Company Information
  57. 6.10.2 Lineagen Business Overview
  58. 6.10.3 Lineagen Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Lineagen Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  60. 6.10.5 Lineagen Recent Developments
  61. 6.11 Invitae
  62. 6.11.1 Invitae Company Information
  63. 6.11.2 Invitae Business Overview
  64. 6.11.3 Invitae Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Invitae Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  66. 6.11.5 Invitae Recent Developments
  67. 6.12 Centogene
  68. 6.12.1 Centogene Company Information
  69. 6.12.2 Centogene Business Overview
  70. 6.12.3 Centogene Chromosomal Microarray Analysis (CMA) Testing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Centogene Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  72. 6.12.5 Centogene Recent Developments
7 North America
  1. 7.1 North America Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
  3. 7.3 North America Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
  3. 8.3 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
  3. 10.3 South America Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst